| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 81.282 | 84.903 | 86.576 | 91.163 | 274.803 | 346.710 | 527.397 | 745.498 | 488.819 | 453.605 |
| Total Income - EUR | 81.282 | 85.260 | 87.172 | 91.164 | 274.814 | 347.860 | 527.399 | 745.501 | 550.847 | 497.155 |
| Total Expenses - EUR | 37.483 | 41.766 | 28.942 | 43.638 | 194.661 | 237.752 | 334.079 | 473.649 | 505.158 | 490.053 |
| Gross Profit/Loss - EUR | 43.800 | 43.494 | 58.230 | 47.526 | 80.153 | 110.108 | 193.320 | 271.852 | 45.689 | 7.102 |
| Net Profit/Loss - EUR | 36.855 | 36.535 | 57.358 | 46.614 | 77.405 | 106.641 | 188.046 | 264.397 | 40.801 | -6.506 |
| Employees | 2 | 5 | 5 | 4 | 7 | 16 | 18 | 17 | 11 | 11 |
Check the financial reports for the company - Eldarad Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 68.740 | 58.319 | 47.777 | 574.565 | 1.205.304 | 1.118.638 | 1.073.643 | 1.010.450 | 974.344 | 820.090 |
| Current Assets | 4.574 | 22.534 | 64.596 | 6.887 | 37.327 | 94.967 | 119.886 | 126.520 | 42.091 | 591.117 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.920 | 22.113 | 64.455 | 5.482 | 16.722 | 29.182 | 26.612 | 121.590 | 26.242 | 584.005 |
| Cash | 654 | 421 | 142 | 1.405 | 20.605 | 65.785 | 93.274 | 4.930 | 15.849 | 7.112 |
| Shareholders Funds | 36.534 | 72.696 | 110.435 | 93.596 | 105.970 | 210.601 | 292.902 | 477.096 | 516.450 | 452.429 |
| Social Capital | 45 | 45 | 44 | 43 | 21.115 | 20.715 | 20.256 | 20.318 | 20.257 | 20.144 |
| Debts | 36.780 | 8.158 | 1.938 | 487.856 | 1.136.661 | 1.003.004 | 900.628 | 659.874 | 499.985 | 416.897 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 541.880 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Eldarad Med Srl